Dr. Habeebbullal Life Sciences Ltd Share Price & Stock Analysis

Dr. Habeebbullal Life Sciences Ltd (BSE: 539267) is a Hyderabad, Telangana-based company in the Life Sciences Tools and Services industry. With a market capitalisation of ₹26 Cr, it ranks #4,249 by market cap among the 6,197 Indian listed companies on FinBizNet, and #9 of 10 in Life Sciences Tools and Services. At ₹12.40 (as of 19 Nov 2026), the share price is 49.5% below its 52-week high of ₹24.55 and 22.2% above its 52-week low of ₹10.15. The share price is down 45.3% over one year and up 6.2% over three months.

Key Metrics

Current Price₹12.40
Market Cap₹26 Cr
BSE Code539267
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services
Sub-IndustryLife Sciences Tools and Services
P/E RatioNot meaningful (loss)
Return on Equity-68.79%
Return on Assets-36.38%
52-Week Range₹10.15 – ₹24.55
1-Year Price Change-45.3%
3-Month Price Change+6.2%
Beta (1Y)-0.57
HeadquartersHyderabad, Telangana
Websitedrhlsl.com

Shareholding and Delivery

Delivery averaged 84.7% of traded volume across 16 BSE sessions (26 Oct 2026 – 19 Nov 2026).

About Dr. Habeebbullal Life Sciences Ltd

Samsrita Labs Limited operates as a biopharmaceutical company in India. The company offers DNA, RNA, and chromosomal-based tests for oncology, pharmacogenomics, infectious diseases, genetic disorders, transplantation typing, and prenatal and pre-implantation genetic diagnostics; and quantitative/real-time polymerase chain reaction (qPCR), multiplex ligation-dependent probe amplification (MLPA), Sanger and Next Generation Sequencing (NGS), karyotype, and fluorescence in-situ hybridization analysis. It is also involved in the stem cell research and therapy, including regenerative medicine, bio-artificial organ scaffold development, nanobiotechnology, nano formulation of cancer drugs, molecular genetics, and molecular virology for the body organs of the liver, pancreas, neural, cardiac, vascular, renal, and orthopedic systems. In addition, company engages in new drug discovery, targeting therapeutic areas, such as Wilson's disease, non-alcoholic steatohepatitis, neuropathic pain, cardiova

Products and Services

1. Healthcare Services-This segment engages in the bio-pharma business. It offers DNA and RNA based tests for infectious diseases, oncology, endocrinology, transplantation typing, haematology, pharmacogenetics, and pre-natal and pre-implantation genetic diagnostics; and karyotype fluorescence in-situ hybridization analysis to detect targeted chromosome abnormalities.

Business Segments

1. Healthcare Services-100%

Dr. Habeebbullal Life Sciences Ltd vs Peers — Life Sciences Tools and Services

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Indegene Ltd₹14,840 Cr40.213.94%₹1,122 Cr+26.1%
Suven Life Sciences Ltd.₹7,951 Crn/m-78.80%₹1 Cr+51.8%
Vimta Labs Ltd₹2,259 Cr29.518.55%₹112 Cr-26.8%
Tarsons Products Limited₹1,730 Cr114.92.26%₹124 Cr+25.7%
Brooks Laboratories Ltd.₹198 Cr7.922.28%₹19 Cr-34.2%
Bilcare Ltd.₹194 Cr108.3-5.21%——
Jeevan Scientific Technology Ltd₹176 Cr129.41.68%—+42.3%
Vivo Bio Tech Ltd.₹37 Crn/m-2.00%₹14 Cr-55.7%
Dr. Habeebbullal Life Sciences Ltd₹26 Crn/m-68.79%—-45.3%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Dr. Habeebbullal Life Sciences Ltd?

Dr. Habeebbullal Life Sciences Ltd is trading at ₹12.40, with a market capitalisation of ₹26 Cr.

Which sector does Dr. Habeebbullal Life Sciences Ltd belong to?

Dr. Habeebbullal Life Sciences Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services space (Life Sciences Tools and Services).

What are the key financial ratios of Dr. Habeebbullal Life Sciences Ltd?

Dr. Habeebbullal Life Sciences Ltd has a return on equity of -68.79%.

What is the stock symbol of Dr. Habeebbullal Life Sciences Ltd?

Dr. Habeebbullal Life Sciences Ltd is listed on the BSE under the scrip code 539267.

How has Dr. Habeebbullal Life Sciences Ltd's share price moved over the past year?

Dr. Habeebbullal Life Sciences Ltd's share price is down 45.3% over one year and up 6.2% over three months. Its 52-week range is ₹10.15 to ₹24.55.

More on FinBizNet

Data as of 19 Nov 2026. Descriptive market data only — not investment advice.